Edwards Lifesciences CorporationEWNYSE
Loading
Debt Growth Recovery in ProgressRecovering
Percentile Rank62
3Y CAGR+3.6%
5Y CAGR+0.9%
Year-over-Year Change
Year-over-year debt growth rate
3Y CAGR
+3.6%/yr
vs +20.3%/yr prior
5Y CAGR
+0.9%/yr
Consistent
Acceleration
-16.7pp
Decelerating
Percentile
P62
Within normal range
vs 5Y Ago
1x
Modest growth
Streak
1 qtr
Consecutive growthRecovering
| Period | Value |
|---|---|
| Q4 2025 | 0.73% |
| Q3 2025 | -0.33% |
| Q2 2025 | 0.46% |
| Q1 2025 | -0.09% |
| Q4 2024 | -0.95% |
| Q3 2024 | 1.98% |
| Q2 2024 | -0.89% |
| Q1 2024 | 2.06% |
| Q4 2023 | -0.87% |
| Q3 2023 | 0.96% |
| Q2 2023 | -0.48% |
| Q1 2023 | -0.51% |
| Q4 2022 | 0.66% |
| Q3 2022 | 0.59% |
| Q2 2022 | -0.78% |
| Q1 2022 | -0.30% |
| Q4 2021 | 0.91% |
| Q3 2021 | -0.01% |
| Q2 2021 | -0.67% |
| Q1 2021 | -0.88% |
| Q4 2020 | 0.70% |
| Q3 2020 | 0.82% |
| Q2 2020 | 1.38% |
| Q1 2020 | -0.53% |
| Q4 2019 | 1.21% |
| Q3 2019 | 0.36% |
| Q2 2019 | 0.32% |
| Q1 2019 | 12.19% |
| Q4 2018 | -50.25% |
| Q3 2018 | 0.03% |
| Q2 2018 | 13.13% |
| Q1 2018 | 1.76% |
| Q4 2017 | 0.23% |
| Q3 2017 | 1.69% |
| Q2 2017 | 19.92% |
| Q1 2017 | 3.11% |
| Q4 2016 | 36.91% |
| Q3 2016 | -0.32% |
| Q2 2016 | 0.05% |
| Q1 2016 | 0.89% |